Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2025

Conditions
Electronic Cigarette UseSmoking, CigaretteNicotine Dependence
Interventions
OTHER

NJOY ACE e-cigarette

Patients will be provided with NJOY ACE electronic cigarettes and 5% nicotine e-liquid cartridges in tobacco flavor for 4 weeks and asked to use the electronic cigarette as a substitute for smoking combustible cigarettes during the 4 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

University of Massachusetts, Boston

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT06472869 - Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening | Biotech Hunter | Biotech Hunter